Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes

被引:0
作者
I Strobel
S Berchtold
A Götze
U Schulze
G Schuler
A Steinkasserer
机构
[1] University of Erlangen,Department of Dermatology
来源
Gene Therapy | 2000年 / 7卷
关键词
dendritic cells; RNA transfection; CTL; immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
The use of tumor antigen loaded dendritic cells (DC) is one of the most promising approaches to induce a tumor specific immune response in vivo. Several strategies have been designed to load DC with tumor antigens. In this study, we investigated the delivery of in vitro transcribed RNA and plasmid DNA into monocyte-derived, ie non-proliferating human DC, using several nonviral transfection methods including electroporation and lipofection. Green fluorescent protein (GFP) was used as a reporter gene and influenza matrix protein 1 (M1) as a model antigen for HLA class I restricted antigen presentation. Using electroporation in combination with DNA or with RNA, up to 11% of DC were GFP-positive. Using liposomes as a vehicle for DNA transport up to 10% of the DC were GFP-positive. A significant increase in transfection efficacy, of up to 20%, was observed when GFP RNA was used in combination with liposomes. Importantly, the RNA transfected DC retained their typical morphological and immunophenotypical characteristics. In addition, DC transfected with M1 RNA were able to stimulate autologous peripheral M1-specific memory cytotoxic T lymphocytes (CTL), as well as M1-specific CTL clones. Furthermore, comparison of DNA-transfected DC with RNA-transfected DC revealed the latter to be far better stimulators of antigen-specific T cells. This RNA transfection technique consequently represents a very promising tool for future immunotherapy strategies.
引用
收藏
页码:2028 / 2035
页数:7
相关论文
共 62 条
  • [1] Romero P(1998) staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes J Exp Med 188 1641-1650
  • [2] Speiser DE(1999) expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes J Exp Med 190 775-782
  • [3] Lee PP(1999)Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients Nature Med 5 677-685
  • [4] Doyle A(1985)Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer J Exp Med 161 1135-1151
  • [5] Banchereau J(1998)Dendritic cells and the control of immunity Nature 392 245-252
  • [6] Steinman RM(1997)Dendritic cells as adjuvants for immune-mediated resistance to tumors J Exp Med 186 1183-1187
  • [7] Schuler G(1995)Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity Nature Med 1 1297-1302
  • [8] Steinman RM(1996)Vaccination of patients with B cell lymphoma using autologous antigen-pulsed dendritic cells Nature Med 2 52-58
  • [9] Mayordomo JI(1996)Phase I clinical trial: T cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen Prostate 29 371-380
  • [10] Hsu FJ(1998)Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nature Med 4 328-332